ストックスクリーナーアプリを入手
249.46
0.54%
-1.36
前日終値:
$250.82
開ける：
$250.6
24時間の取引高:
3.99M
Relative Volume:
0.62
時価総額：
$440.83B
収益：
$62.82B
当期純損益:
$3.60B
株価収益率:
123.04
EPS:
2.0274
ネットキャッシュフロー:
$19.98B
1週間 パフォーマンス:
+1.39%
1か月 パフォーマンス:
+1.91%
6か月 パフォーマンス:
+7.76%
1年 パフォーマンス:
+21.88%
1日の値動き範囲:
$247.68
$250.61
1週間の範囲:
$244.03
$255.29
52週間の値動き範囲:
$190.75
$267.47
Abbvie Inc Stock (ABBV) Company Profile
Compare ABBV vs LLY, JNJ, MRK, NVS
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ABBV
Abbvie Inc
|
249.46 | 439.59B | 62.82B | 3.60B | 19.98B | 2.0274 |
LLY
Lilly Eli Co
|
1,180.16 | 1.09T | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
260.35 | 628.65B | 97.93B | 21.04B | 17.80B | 8.6278 |
MRK
Merck Co Inc
|
135.84 | 327.94B | 65.51B | 8.93B | 14.12B | 3.5532 |
NVS
Novartis Ag Adr
|
150.88 | 289.52B | 54.66B | 13.58B | 16.05B | 7.0171 |
Abbvie Inc Stock (ABBV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-30 | アップグレード | BofA Securities | Neutral → Buy |
| 2026-04-21 | 開始されました | Canaccord Genuity | Buy |
| 2026-02-25 | 開始されました | RBC Capital Mkts | Outperform |
| 2026-02-20 | 開始されました | Barclays | Overweight |
| 2026-01-08 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2026-01-07 | 再開されました | UBS | Neutral |
| 2025-12-10 | アップグレード | HSBC Securities | Hold → Buy |
| 2025-11-13 | 開始されました | Scotiabank | Sector Outperform |
| 2025-11-04 | ダウングレード | DZ Bank | Buy → Hold |
| 2025-10-14 | ダウングレード | Erste Group | Buy → Hold |
| 2025-10-01 | ダウングレード | HSBC Securities | Buy → Hold |
| 2025-09-17 | アップグレード | Berenberg | Hold → Buy |
| 2025-08-12 | 再開されました | Piper Sandler | Overweight |
| 2025-08-07 | アップグレード | Daiwa Securities | Neutral → Outperform |
| 2025-05-14 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-04-22 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-12-10 | 再開されました | BofA Securities | Neutral |
| 2024-12-05 | ダウングレード | Daiwa Securities | Outperform → Neutral |
| 2024-11-22 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2024-11-15 | 開始されました | Wolfe Research | Outperform |
| 2024-11-04 | アップグレード | Argus | Hold → Buy |
| 2024-10-17 | 開始されました | Bernstein | Mkt Perform |
| 2024-06-05 | アップグレード | HSBC Securities | Hold → Buy |
| 2024-05-17 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-01-29 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2023-12-18 | ダウングレード | HSBC Securities | Buy → Hold |
| 2023-12-11 | アップグレード | Goldman | Neutral → Buy |
| 2023-11-09 | 開始されました | Deutsche Bank | Hold |
| 2023-10-30 | アップグレード | Barclays | Equal Weight → Overweight |
| 2023-10-20 | 再開されました | UBS | Neutral |
| 2023-09-29 | 開始されました | Raymond James | Outperform |
| 2023-07-25 | 開始されました | William Blair | Mkt Perform |
| 2023-07-14 | 開始されました | HSBC Securities | Buy |
| 2023-04-05 | ダウングレード | Argus | Buy → Hold |
| 2023-03-01 | 開始されました | Guggenheim | Buy |
| 2023-02-22 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2023-02-10 | アップグレード | SVB Securities | Underperform → Market Perform |
| 2022-11-18 | 開始されました | Credit Suisse | Outperform |
| 2022-11-08 | ダウングレード | Societe Generale | Buy → Hold |
| 2022-08-01 | ダウングレード | Atlantic Equities | Overweight → Neutral |
| 2022-05-23 | 開始されました | SVB Leerink | Underperform |
| 2022-05-06 | ダウングレード | Daiwa Securities | Outperform → Neutral |
| 2022-04-06 | 再開されました | Morgan Stanley | Overweight |
| 2022-02-28 | ダウングレード | UBS | Buy → Neutral |
| 2022-02-03 | 繰り返されました | BMO Capital Markets | Outperform |
| 2022-02-03 | 繰り返されました | Barclays | Equal Weight |
| 2022-02-03 | 繰り返されました | BofA Securities | Neutral |
| 2022-02-03 | 繰り返されました | Goldman | Neutral |
| 2022-01-13 | 開始されました | Redburn | Buy |
| 2022-01-12 | 繰り返されました | BMO Capital Markets | Outperform |
| 2021-12-09 | 再開されました | Wells Fargo | Overweight |
| 2021-11-23 | アップグレード | Societe Generale | Hold → Buy |
| 2021-07-27 | 再開されました | Truist | Buy |
| 2021-04-07 | 再開されました | RBC Capital Mkts | Outperform |
| 2020-11-10 | 再開されました | Bernstein | Outperform |
| 2020-09-29 | 開始されました | Berenberg | Hold |
| 2020-06-23 | アップグレード | Atlantic Equities | Neutral → Overweight |
| 2020-06-09 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | アップグレード | Argus | Hold → Buy |
| 2020-05-18 | 再開されました | BofA/Merrill | Neutral |
| 2020-05-12 | アップグレード | JP Morgan | Neutral → Overweight |
| 2020-05-11 | 再開されました | Morgan Stanley | Overweight |
| 2020-04-20 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-03-23 | ダウングレード | Societe Generale | Buy → Hold |
| 2020-02-27 | 開始されました | Barclays | Equal Weight |
| 2020-02-06 | 開始されました | Mizuho | Buy |
| 2020-01-07 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2019-12-26 | 繰り返されました | Cowen | Outperform |
| 2019-09-26 | アップグレード | Citigroup | Neutral → Buy |
| 2019-08-20 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2019-06-27 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2019-06-26 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-28 | 開始されました | Goldman | Neutral |
| 2019-04-29 | アップグレード | BMO Capital Markets | Underperform → Market Perform |
すべてを表示
Abbvie Inc (ABBV) 最新ニュース
Neuroscience Is Becoming AbbVie's Quiet Powerhouse -- and Management Now Sees $12.7 Billion in Sales This Year - AOL.com
RWQ Financial Management Services Inc. Acquires 31,510 Shares of AbbVie Inc. $ABBV - MarketBeat
Mirae Asset Global Investments Co. Ltd. Has $124.56 Million Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Synergy Asset Management LLC Grows Stock Position in AbbVie Inc. $ABBV - MarketBeat
Campbell Newman Asset Management Inc. Sells 10,481 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie (ABBV) Stock May Trade At A Premium Despite Cash Flow Upside - Yahoo Finance
SOA Wealth Advisors LLC. Sells 13,215 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Stake Boosted by Envestnet Portfolio Solutions Inc. - MarketBeat
2 Reasons to Like ABBV and 1 to Stay Skeptical - Yahoo Finance
AbbVie Defends Its Turf, But Leaves One Big Question Open - trefis.com
AbbVie vs. Bristol-Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026? - Yahoo Finance
AbbVie vs. Bristol-Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Can ABBV's Neuroscience Drugs Drive Growth in the Second Half of 2026? - Yahoo Finance
AbbVie (NYSE:ABBV): Is More Momentum Ahead? - Kalkine Media
AbbVie Inc. (ABBV) Stock Forecasts - Yahoo Finance
Gateway Investment Advisers LLC Sells 13,696 Shares of AbbVie Inc. $ABBV - MarketBeat
Clarity Financial LLC Has $50.02 Million Stock Position in AbbVie Inc. $ABBV - MarketBeat
Could AbbVie Inc. (ABBV) Win as Genmab A/S (GMAB) Faces a New Regulatory Test for Epcoritamab? - Yahoo Finance
Could AbbVie Inc. (ABBV)’s Post-Humira Transformation Drive the Next Phase of Growth? - Yahoo Finance
Wolfe Research Issues Rare Double Upgrade for Biogen and AbbVie, Setting $300 Targets - finance.biggo.com
Why Is AbbVie (NYSE:ABBV) In Focus as Immunology Franchise Draws Attention Worth Watching? - kalkinemedia.com
ABBV Upgraded by Wolfe Research -- Price Target Raised to $300 - GuruFocus
Could Why Is AbbVie (NYSE:ABBV) in View as the Broad Market Nears Records Stay in Focus? - Kalkine Media
Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation - Yahoo Finance
Here Are Thursday’s Top Wall Street Analyst Research Calls: Abbott Labs, AbbVie, Akamai Technologies, Five Below, Keurig Dr. Pepper, Salesforce, Stryker, StubHub, and More - Yahoo Finance
Wolfe Upgrades AbbVie to Outperform From Peer Perform, Price Target is $300 - marketscreener.com
AbbVie Inc. $ABBV Shares Acquired by Mission Wealth Management LP - MarketBeat
Moody Lynn Lieberson & Walker LLC Has $42.52 Million Holdings in AbbVie Inc. $ABBV - MarketBeat
Harmony Asset Management LLC Boosts Holdings in AbbVie Inc. $ABBV - MarketBeat
Riverchase Wealth Management LLC Buys New Position in AbbVie Inc. $ABBV - MarketBeat
FOCUSED GLOBAL GROWTH FUND's AbbVie Inc(ABBV) Holding History - GuruFocus
How ABBV Stock Moved Away From Its Peer Group - trefis.com
Johnson & Johnson vs AbbVie: Safe Dividend vs Higher Yield - 24/7 Wall St.
Horizon Multi-Factor U.S. Equity Fund's AbbVie Inc(ABBV) Holding History - GuruFocus
Prediction: AbbVie Will End The Year at This Price - AOL.com
AbbVie Inc. $ABBV Shares Bought by Wedge Capital Management L L P NC - MarketBeat
BTIG downgrades Apogee Therapeutics stock rating after AbbVie deal - Investing.com
Cardinal Capital Management Inc. Buys 21,206 Shares of AbbVie Inc. $ABBV - MarketBeat
GODSEY & GIBB, INC's AbbVie Inc(ABBV) Holding History - GuruFocus
VIP Health Care Portfolio's AbbVie Inc(ABBV) Holding History - GuruFocus
AbbVie (ABBV) Wins Canada Reimbursement Backing For Adult Migraine Treatment - Yahoo Finance
AbbVie (ABBV) Gains On Botox Filing, Is The 9% Discount Still There? - Yahoo Finance
Why Is AbbVie (NYSE:ABBV) the Healthcare Name Riding Its Immunology Momentum? - Kalkine Media
AbbVie vs. CVS Health: Which Healthcare Stock Is a Better Buy in 2026? - Yahoo Finance
ABBV Maintained by BNP Paribas -- Price Target Raised to $247 - GuruFocus
Pfizer vs AbbVie: What's the Better Dividend Stock for Investors in 2026? - AOL.com
BNP Paribas Exane Forecasts Strong Price Appreciation for AbbVie (NYSE:ABBV) Stock - marketbeat.com
Integrity Advisory Solutions, LLC's AbbVie Inc(ABBV) Holding History - GuruFocus
BNP Paribas Adjusts Price Target on AbbVie to $247 From $218, Maintains Neutral Rating - marketscreener.com
Allergan Aesthetics Refreshes Allergan Partner Privileges® to Better Support Today's Modern Aesthetics Practices - Yahoo! Finance Canada
AbbVie Piles on $8 Billion in Debt for Its Apogee Deal -- Should Dividend Investors Worry? - Yahoo Finance
Abbvie Inc (ABBV) 財務データ
収益
当期純利益
現金流量
EPS
0.21%
0.55%
大文字化:
|
ボリューム (24 時間):